B+
Bull case
25%
Probability
Target price
$72.00
Analysis reference price unavailable
Analysis 2026-05-08 · RankAlpha Sentiment Codex
USPH
US Physical TherapyDNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$63.00
Analysis reference price unavailable
Analysis 2026-05-08 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$52.00
Analysis reference price unavailable
Analysis 2026-05-08 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-05-08
Recent news sentiment (30D)
-0.2
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+38.6
Score
AI commentary
Tone is mixed-to-negative after earnings. Checked company filings support record revenue and reaffirmed guidance, but trusted secondary coverage said Q1 adjusted EPS of $0.46 missed a $0.55 consensus and revenue of $198.3 million missed roughly $203.5 million. MarketBeat search coverage indicated the stock traded near $62.18 on May 7, about 15.6% below the pre-print level, and live price data on May 8 showed only a partial stabilization around $59.3. No robust post-print analyst target-revision set was available in checked sources by May 8, which keeps this as a cautious monitoring view rather than a conviction rebound call.
RankAlpha Sentiment Codex - 2026-05-08
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-31catalystPost-earnings digestion after Q1 miss but guidance reaffirmationMedium impact
Q1 net revenue rose 7.9% to $198.3 million, adjusted operating results per share were $0.46, and management reaffirmed full-year 2026 adjusted EBITDA guidance of $102 million to $106 million; the near-term debate is whether the earnings miss is treated as temporary while hospital-alliance ramp begins in May and 2H execution benefits are tested [#8-K-2026-05-06].
2026-09-30eventHospital-alliance ramp and acquisition integration through 2H 2026High impact
Management said two previously announced strategic hospital alliances should be accretive to revenue, EBITDA and margins, with phased ramp-up beginning in May 2026; upon full integration, USPH estimated at least $6 million of annualized EBITDA impact from the Metro clinics and at least $1.3 million from the second subsidiary partner affiliation [#8-K-2026-05-06].
2026-12-31catalystOperational efficiency initiatives and balance-sheet capacityHigh impact
Management highlighted semi-virtualized front desk processes, ambient-listening documentation tools, remote therapeutic monitoring, and cash-pay program expansion as 2H margin and productivity levers, while the new $450 million facility extends capital for growth; execution must offset recent physical-therapy margin pressure and higher borrowings [#8-K-2026-05-06] [#10-Q-2026-05-08].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-08 • Updated nightlySource: Internal modelMethodology